TRIMT is an inventor-founded, science and data driven company, managed and operated by experts with a strong scientific background who are supported by an interdisciplinary board of advisors.
For pharmaceutical and clinical developments addressing highly unmet clinical needs, TRIMT rely on a consolidated network of academic and clinical collaborations and a top choice of industrial partners.
For the benefit of patients, TRIMT strive to exploit the full potential of its unique IP portfolio with a stategic, diversified selection of short and long term development goals. TRIMT value a creative, out-of-the-box thinking and communication approach leading to disruptive innovation.
As Nukleon, we serve as the authorized distributor of the Trivehexin product of TRIMT in the Turkish market.
For more information, you can visit the link www.trimt.de.